Comparative Activities of Novel Therapeutic Agents against Molecularly Characterized Clinical Carbapenem-Resistant <i>Enterobacterales</i> Isolates
Jocelyn Qi-Min Teo, Hong Yi Chang, Si Hui Tan, Cheng Yee Tang, Rick Twee‐Hee Ong, Karrie Kwan Ki Ko, Shimin Jasmine Chung, Thuan Tong Tan, Andrea Lay‐Hoon Kwa
Abstract
infections. We note also that antibiotic activity is influenced by genotypes and that understanding the geographic region's molecular epidemiology could aid in the definition of the presumptive utility of novel agents and contribute to antibiotic decision-making.
Topics & Concepts
Ceftazidime/avibactamCarbapenemMeropenemCarbapenem-resistant enterobacteriaceaeMicrobiologyImipenemBiologyEnterobacteriaceae InfectionsMedicineEnterobacteriaceaeCeftazidimeAntibioticsAntibiotic resistanceGeneticsPseudomonas aeruginosaBacteriaGeneEscherichia coliAntibiotic Resistance in BacteriaEnterobacteriaceae and Cronobacter ResearchPlant Pathogenic Bacteria Studies